KOPRED 0.5% EYE DROP (Each ml contains Predrusolin Acetat 0.5%w/v

Indications

• Metabolic disorders
• Energy production support
• Sensory perception enhancement

Dosage

Children: Refer to the BNF for Children for appropriate pediatric dosing guidelines.

Adults: Refer to specific guidelines or clinical protocols for dosing recommendations, as doses may vary based on the clinical context.

Mechanism of action

Acetat functions as an important metabolic intermediate in the citric acid cycle (Krebs cycle), where it contributes to energy production. It is also involved in the olfactory signaling pathway, where it may influence sensory perception.

Pharmacodynamics

As a metabolic precursor, acetate influences various physiological processes, including energy metabolism and the synthesis of important biomolecules. Its role in the olfactory signaling pathway indicates its involvement in sensory perception, potentially affecting taste and smell.

Pharmacokinetics

Acetate is rapidly absorbed and metabolized in the body. It is primarily converted into acetyl-CoA, a central metabolite that enters the citric acid cycle. The elimination of acetate occurs mainly through urinary excretion and metabolic conversion.

Pregnancy

There is no well-controlled study of acetat in pregnant women. Use only if clearly needed.

Breast-feeding

It is not known whether acetat is excreted in human milk. Use with caution.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

Indications

• Allergic disorders
• Autoimmune diseases
• Inflammatory bowel disease
• Bronchial asthma
• Rheumatoid arthritis
• Dermatological conditions
• Certain cancers
• Organ transplant rejection prophylaxis

Dosage

Children: Refer to specific guidelines or clinical protocols for appropriate dosing, as it varies based on the condition being treated.

Adults: Refer to specific guidelines or clinical protocols for appropriate dosing, as it varies based on the condition being treated.

Mechanism of action

Predrusolin exerts its pharmacological effects by binding to the glucocorticoid receptor, which then translocates to the nucleus and regulates gene expression. This results in decreased production of pro-inflammatory cytokines and mediators, leading to a reduction in inflammation and modulation of the immune system.

Pharmacodynamics

The anti-inflammatory effects of predrusolin include inhibition of leukocyte infiltration at the site of inflammation, suppression of humoral immune responses, and a reduction in the production of various inflammatory mediators. Additionally, it can affect carbohydrate, protein, and fat metabolism, influencing the overall energy balance in the body.

Pharmacokinetics

Predrusolin is typically well-absorbed when administered orally, with peak plasma concentrations occurring within 1 to 2 hours. It is extensively metabolized in the liver, primarily through the cytochrome P450 system, and its metabolites are excreted by the kidneys. The drug has a half-life of approximately 3 to 4 hours, though this can vary based on factors such as dosage and individual patient metabolism.

Contra-indications

• Active systemic fungal infections
• Hypersensitivity to predrusolin or any of its components
• Administration of live vaccines in immunocompromised patients

Adverse effects

• Increased risk of infections
• Gastrointestinal disturbances such as nausea and vomiting
• Mood changes including euphoria or depression
• Altered glucose metabolism leading to hyperglycemia
• Hypertension
• Osteoporosis with long-term use
• Dermatological reactions such as acne or thinning skin

Interactions

• Non-steroidal anti-inflammatory drugs (NSAIDs) may increase the risk of gastrointestinal bleeding
• Anticoagulants may have altered effects
• Vaccines may be less effective when administered concurrently
• CYP3A4 inducers or inhibitors may affect predrusolin metabolism

Precautions

• Monitor for signs of infection during therapy
• Use with caution in patients with diabetes or hypertension
• Taper the dose gradually to avoid adrenal insufficiency after long-term use
• Assess bone density in long-term users

Pregnancy

Predrusolin is classified as pregnancy category C. It should be used only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Predrusolin is excreted in breast milk. Caution should be exercised when administered to a nursing woman.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Formulations

• Tablets
• Oral solution
• Injection (intravenous or intramuscular)